Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$49,182,388
-$39,517,418 QoQ
Shares Held
2,042,458
-35.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#175
of 2,826 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $1,569,589,305 across 10 Drug Manufacturers - General names. PFE ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,523,337 | $478,475,161 | |
| 2 | LLY |
ELI LILLY & Co
|
348,001 | $417,402,874 | |
| 3 | JNJ |
Johnson & Johnson
|
852,974 | $216,629,806 | |
| 4 | ABBV |
AbbVie Inc.
|
583,795 | $146,906,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
830,507 | $106,720,149 | |
| 6 | AMGN |
Amgen Inc
|
164,973 | $59,740,022 | |
| 7 | PFE |
Pfizer Inc
This page
|
2,042,458 | $49,182,388 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
381,309 | $48,174,579 |
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,182,388 | 2,042,458 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $88,699,806 | 3,158,825 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $76,075,102 | 3,055,225 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $73,716,391 | 2,893,108 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $80,460,704 | 3,319,336 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $86,927,172 | 3,430,433 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $92,775,171 | 3,496,991 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||